Literature DB >> 21455205

Redemption for the field of oncolytic virotherapy.

David H Kirn.   

Abstract

Mesh：

Year:  2011        PMID： 21455205      PMCID： PMC3070109          DOI： 10.1038/mt.2011.45

Source DB:  PubMed          Journal:  Mol Ther        ISSN： 1525-0016            Impact factor:   11.454


× No keyword cloud information.
  5 in total

1.  Establishing the Lysine-rich Protein CEST Reporter Gene as a CEST MR Imaging Detector for Oncolytic Virotherapy.

Authors:  Christian T Farrar; Jason S Buhrman; Guanshu Liu; Anne Kleijn; Martine L M Lamfers; Michael T McMahon; Assaf A Gilad; Giulia Fulci
Journal:  Radiology       Date:  2015-02-13       Impact factor: 11.105

2.  Incorporation of host complement regulatory proteins into Newcastle disease virus enhances complement evasion.

Authors:  Moanaro Biswas; John B Johnson; Sandeep R P Kumar; Griffith D Parks; Subbiah Elankumarana; Elankumaran Subbiah
Journal:  J Virol       Date:  2012-09-12       Impact factor: 5.103

3.  Regulating cytokine function enhances safety and activity of genetic cancer therapies.

Authors:  Hannah Chen; Padma Sampath; Weizhou Hou; Stephen H Thorne
Journal:  Mol Ther       Date:  2012-11-13       Impact factor: 11.454

4.  Indole-3-carbinol (I3C) increases apoptosis, represses growth of cancer cells, and enhances adenovirus-mediated oncolysis.

Authors:  Lan Chen; Pei-Hsin Cheng; Xiao-Mei Rao; Kelly M McMasters; Heshan Sam Zhou
Journal:  Cancer Biol Ther       Date:  2014-06-27       Impact factor: 4.742

Review 5.  The sodium iodide symporter (NIS) as an imaging reporter for gene, viral, and cell-based therapies.

Authors:  Alan R Penheiter; Stephen J Russell; Stephanie K Carlson
Journal:  Curr Gene Ther       Date:  2012-02-01       Impact factor: 4.391
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.